2023-504055-27-00CompletedPhase 1
A study to evaluate the effect of multiple doses of carbamazepine and itraconazole on how long JNJ-55308942 stays in the body (pharmacokinetics) in healthy adults.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Jun 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 31 Aug 2023
- Start date
- 5 Jan 2024
- Lead sponsor
- Janssen - Cilag International
- EU CT number
- 2023-504055-27-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 48
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Janssen Pharmaceutica | Antwerp | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.